Seeking Alpha


Send Message
View as an RSS Feed
View NNVC-archive-dot-org's Comments BY TICKER:
Latest  |  Highest rated
  • Nanoviricides to restart Ebola program [View news story]
    Right after they finish with their rabies treatment, their herpes treatment, and all the other ones they were "developing" until they could get a couple press releases out.
    Aug 4, 2014. 02:44 PM | Likes Like |Link to Comment
  • NanoViricides Incorporated: A Biotech Innovator Bound Only By Its Own Ambition [View article]
    Pfizer spent $7.8 billion in R&D in 2012, and got five drug approvals. That's over $1 billion per drug. If you wish to go back further, I believe they spent $9 billion in 2011, so I doubt the numbers will look much better.

    Suppose NNVC, despite never having a drug approved before, can develop a drug for one-fifth the cost? That's still $200 million. They don't have that kind of money.

    Where will the other $186 million come from? Selling shares is the logical answer, since that's how NNVC has always done it in the past.

    Or... they can keep doing things at a glacial pace.
    Nov 15, 2013. 02:50 PM | Likes Like |Link to Comment
  • NanoViricides Incorporated: A Biotech Innovator Bound Only By Its Own Ambition [View article]
    To call NNVC's finances "quite healthy" is to completely misunderstand the process of drug development. According to an article last year in Forbes (hardly the "liberal media"). it costs companies about $1 billion per each approved drug. So NNVC having $14 million in the bank is miniscule. Maybe even laughable.

    You say "they haven't just designed a drug". Well, they haven't even done that yet. It hasn't been tested on humans in any way, shape or form. When it does get tested in humans, it is over 90% likely to fail - another fact found in the Forbes article.

    It's nice to have accomplished people on an advisory board, but the number of drugs developed by the CEO and the president of this company - combined - is zero.

    I would say you glossed over the constant stream of delays and missed deadlines by the executive team, but I don't even see them mentioned. I think their history, more than anything else, points to reasons not to trust them.
    Nov 6, 2013. 12:02 AM | 1 Like Like |Link to Comment
  • Cellceutix: Are 2 Guys Worth $200 Million? [View article]

    At different times, Menon has claimed to have a PhD from Harvard and from Kerala University.

    Is either true?

    So we have a guy who faked credentials who tells everyone to trust his company's drug is effective.... because his other company says it's effective.

    Hardly the scientific method at work.
    Jan 10, 2013. 01:21 PM | 1 Like Like |Link to Comment
  • Got Flu? [View instapost]
    Sorry to hear, Kirk, especiallly since they keep increasing the float exponentially...
    Dec 25, 2012. 05:25 PM | Likes Like |Link to Comment